Phylodynamic analysis in the understanding of the current COVID-19 pandemic and its utility in vaccine and antiviral design and assessment

Over the last decades, the use of phylogenetic methods in the study of emerging infectious diseases has gained considerable traction in public health. Particularly, the integration of phylogenetic analyses with the understanding of the pathogen dynamics at the population level has provided powerful...

Full description

Bibliographic Details
Main Authors: Jaime A. Cardona-Ospina, Diana M. Rojas-Gallardo, Sandra C. Garzón-Castaño, Erika V. Jiménez-Posada, Alfonso J. Rodríguez-Morales
Format: Article
Language:English
Published: Taylor & Francis Group 2021-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2021.1880254
_version_ 1797674561096908800
author Jaime A. Cardona-Ospina
Diana M. Rojas-Gallardo
Sandra C. Garzón-Castaño
Erika V. Jiménez-Posada
Alfonso J. Rodríguez-Morales
author_facet Jaime A. Cardona-Ospina
Diana M. Rojas-Gallardo
Sandra C. Garzón-Castaño
Erika V. Jiménez-Posada
Alfonso J. Rodríguez-Morales
author_sort Jaime A. Cardona-Ospina
collection DOAJ
description Over the last decades, the use of phylogenetic methods in the study of emerging infectious diseases has gained considerable traction in public health. Particularly, the integration of phylogenetic analyses with the understanding of the pathogen dynamics at the population level has provided powerful tools for epidemiological surveillance systems. In the same way, the development of statistical methods and theory, as well as improvement of computational efficiency for evolutionary analysis, has expanded the use of these tools for vaccine and antiviral development. Today with the Coronavirus Disease 2019 (COVID-19), this seems to be critical. In this article, we discuss how the application of phylodynamic analysis can improve the understanding of current pandemic dynamics as well as the design, selection, and evaluation of vaccine candidates and antivirals.
first_indexed 2024-03-11T22:00:48Z
format Article
id doaj.art-93bf040076ad4fa594dd0fa3bbe05378
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T22:00:48Z
publishDate 2021-08-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-93bf040076ad4fa594dd0fa3bbe053782023-09-25T11:13:19ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2021-08-011782437244410.1080/21645515.2021.18802541880254Phylodynamic analysis in the understanding of the current COVID-19 pandemic and its utility in vaccine and antiviral design and assessmentJaime A. Cardona-Ospina0Diana M. Rojas-Gallardo1Sandra C. Garzón-Castaño2Erika V. Jiménez-Posada3Alfonso J. Rodríguez-Morales4Fundación Universitaria Autónoma de Las AméricasFundación Universitaria Autónoma de Las AméricasFundación Universitaria Autónoma de Las AméricasInstituto Para La Investigación en Ciencias Biomédicas - Sci-HelpFundación Universitaria Autónoma de Las AméricasOver the last decades, the use of phylogenetic methods in the study of emerging infectious diseases has gained considerable traction in public health. Particularly, the integration of phylogenetic analyses with the understanding of the pathogen dynamics at the population level has provided powerful tools for epidemiological surveillance systems. In the same way, the development of statistical methods and theory, as well as improvement of computational efficiency for evolutionary analysis, has expanded the use of these tools for vaccine and antiviral development. Today with the Coronavirus Disease 2019 (COVID-19), this seems to be critical. In this article, we discuss how the application of phylodynamic analysis can improve the understanding of current pandemic dynamics as well as the design, selection, and evaluation of vaccine candidates and antivirals.http://dx.doi.org/10.1080/21645515.2021.1880254sars-cov-2covid-19phylodynamicvaccinesantivirals
spellingShingle Jaime A. Cardona-Ospina
Diana M. Rojas-Gallardo
Sandra C. Garzón-Castaño
Erika V. Jiménez-Posada
Alfonso J. Rodríguez-Morales
Phylodynamic analysis in the understanding of the current COVID-19 pandemic and its utility in vaccine and antiviral design and assessment
Human Vaccines & Immunotherapeutics
sars-cov-2
covid-19
phylodynamic
vaccines
antivirals
title Phylodynamic analysis in the understanding of the current COVID-19 pandemic and its utility in vaccine and antiviral design and assessment
title_full Phylodynamic analysis in the understanding of the current COVID-19 pandemic and its utility in vaccine and antiviral design and assessment
title_fullStr Phylodynamic analysis in the understanding of the current COVID-19 pandemic and its utility in vaccine and antiviral design and assessment
title_full_unstemmed Phylodynamic analysis in the understanding of the current COVID-19 pandemic and its utility in vaccine and antiviral design and assessment
title_short Phylodynamic analysis in the understanding of the current COVID-19 pandemic and its utility in vaccine and antiviral design and assessment
title_sort phylodynamic analysis in the understanding of the current covid 19 pandemic and its utility in vaccine and antiviral design and assessment
topic sars-cov-2
covid-19
phylodynamic
vaccines
antivirals
url http://dx.doi.org/10.1080/21645515.2021.1880254
work_keys_str_mv AT jaimeacardonaospina phylodynamicanalysisintheunderstandingofthecurrentcovid19pandemicanditsutilityinvaccineandantiviraldesignandassessment
AT dianamrojasgallardo phylodynamicanalysisintheunderstandingofthecurrentcovid19pandemicanditsutilityinvaccineandantiviraldesignandassessment
AT sandracgarzoncastano phylodynamicanalysisintheunderstandingofthecurrentcovid19pandemicanditsutilityinvaccineandantiviraldesignandassessment
AT erikavjimenezposada phylodynamicanalysisintheunderstandingofthecurrentcovid19pandemicanditsutilityinvaccineandantiviraldesignandassessment
AT alfonsojrodriguezmorales phylodynamicanalysisintheunderstandingofthecurrentcovid19pandemicanditsutilityinvaccineandantiviraldesignandassessment